Key result
Epicardial adipose tissue has emerged as a potential biomarker and therapeutic target in paradoxical low-gradient aortic stenosis, influencing pathology through mechanical and metabolic alterations.
Why the study?
Paradoxical low-flow, low-gradient aortic stenosis with preserved ejection fraction carries a worse prognosis than high-gradient aortic stenosis, highlighting the need to explore epicardial adipose tissue as a biomarker and therapeutic target.
Epicardial adipose tissue is a metabolically active depot that may serve as a biomarker and therapeutic target in paradoxical low-flow, low-gradient aortic stenosis with preserved ejection fraction.
Answers are grounded in this paper and cite their sources.
Supports EAT evaluation in paradoxical low-gradient AS; hypothesis-generating for therapeutic targeting.
Paradoxical low-flow, low-gradient (LFLG) aortic stenosis (AS) with preserved ejection fraction (ASpEF) is a severe AS subtype associated with worse prognosis and increased mortality compared with high-gradient AS. Epicardial adipose tissue (EAT), a metabolically active visceral fat depot surrounding the myocardium, has emerged as a potential biomarker and therapeutic target in this population. EAT influences myocardial and valvular pathology through mechanical compression, metabolic alterations, and secretion of inflammatory mediators such as IL-6, MCP-1, and TNF-α, contributing to left ventricular remodeling and aortic valve degeneration. Recent metabolomic studies demonstrate significant associations between EAT thickness and both positively and negatively correlated metabolites, underscoring its complex role in disease progression. Despite its promise, challenges remain due to limited understanding of EAT-myocardium interactions, variable patient presentation, and confounding factors such as insulin resistance and obesity. Further research is warranted to clarify EAT's pathophysiological role, prognostic value, and therapeutic potential in managing paradoxical LFLG ASpEF.
No takes yet. Share an insight, caveat, or question.
Abbas et al. (2025) conducted a review in Paradoxical low-flow, low-gradient aortic stenosis with preserved ejection fraction. Epicardial adipose tissue was evaluated. Epicardial adipose tissue has emerged as a potential biomarker and therapeutic target in paradoxical low-gradient aortic stenosis, influencing pathology through mechanical and metabolic alterations.
Synapse has enriched 10 related papers. Consider them for comparative context: